FDA delivers clearance for Johnson & Johnson’s OneTouch VerioSync blood glucose monitoring system.
Milpitas, Calif.-based LifeScan Inc.’s OneTouch VerioSync Blood Glucose Monitoring System received clearance from the US Food & Drug Administration (FDA). It is the first meter to send, automatically, blood glucose results wirelessly via Bluetooth technology to an iPhone, iPad or iPod touch using the OneTouch Reveal mobile app.
"For so many people, their iPhone, iPad or iPod touch have become a tool of choice to help organize and take charge of their daily lives," states Ty Lee, vice president of marketing, representing the products of LifeScan Inc. & Animas Corp. "For people with diabetes, the new OneTouch VerioSync System will enable them to use their iOS device to view and share their blood glucose results wirelessly, in much the same way they rely on them in other areas of their lives."
Through the OneTouch Reveal mobile app, users will be able to view a variety of personalized information directly on their iPhone, iPad, or iPod touch, including a 14-day summary of blood sugar test results, simple visuals showing the percentage of test results within target range. Users are then able to share that information via email or text with their care providers, family, or friends.